Covance Is Now Labcorp Drug Development

We are one global company innovating for millions – together, continuing to bring you more advanced medical breakthroughs.

Learn More


From Biomarkers to Companion Diagnostics: Transforming the Therapeutic Landscape of Non-Small Cell Lung Cancer Case Study

This case study offers insights from multiple success stories of partnering with leading pharmaceutical companies to investigate and validate biomarkers, manage clinical trials and launch companion diagnostic assays for NSCLC.

Filed In

Diagnostics (Companion)
Personalized & Precision
Therapies - Cell
Therapies - Gene